DOCSLIB.ORG

Gated Equilibrium Radionuclide Ventriculography Version 3.0, Approved June 15, 2002

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Gated Equilibrium Radionuclide Ventriculography Version 3.0, Approved June 15, 2002 Society of Nuclear Medicine Procedure Guideline for Gated Equilibrium Radionuclide Ventriculography version 3.0, approved June 15, 2002 A u t h o r s : Jac Scheiner, MD (Brown Medical School, Providence, RI); Albert Sinusas, MD (Yale University School of Medicine, New Haven, CT); Mark D. Wittry, MD (Saint Louis University, St. Louis, MO); Henry D. Royal, MD (Mallinck- rodt Institute of Radiology, St. Louis, MO); Josef Machac, MD (Mount Sinai School of Medicine of New York University, NY); Helena R. Balon, MD (William Beaumont Hospital, Royal Oak, MI); and Otto Lang, MD (Third Medical School, Charles University, Prague, Czech Republic). I. P u r p o s e 6 . Stroke volume ratios B . Common clinical settings in which RVG may The purpose of this guideline is to assist nuclear be useful include: medicine practioners in recommending, perform- 1 . Known or suspected coronary artery disease ing, interpreting, and reporting the results of gated ( C A D ) equilibrium radionuclide ventriculography. a . CAD without myocardial infarction (MI) b . Remote MI I I . Background Information and Definitions c . Acute MI (however, these patients usu- ally should not undergo exercise stress in Gated equilibrium radionuclide ventriculography the first 48 hours after acute MI) (RVG) is a procedure in which the patient’s red blood cells (RBCs) are radiolabeled and electrocar- 2 . To help distinguish systolic from diastolic diograph (ECG)-gated cardiac scintigraphy is ob- causes of congestive heart failure (CHF) in tained. Single or multiple measurements of left patients with known or suspected CHF and/or right ventricular function are obtained. Al- 3 . Evaluation of cardiac function in patients ternative terminologies for this technique include undergoing chemotherapy gated cardiac blood-pool imaging, multigated ac- 4 . Assessment of ventricular function in pa- quisition (MUGA), and gated equilibrium ra- tients with valvular heart disease dionuclide angiography (RNA). An RVG may be used in the conditions listed Data are collected from several hundred cardiac above for (a) determining long-term progno- cycles to generate an image set of the beating heart sis; (b) assessing short-term risk (e.g., preop- that is presented as a single, composite cardiac cy- erative evaluation); and (c) monitoring re- cle. The method can be used to assess (a) regional sponse to surgery or other therapeutic and global wall motion; (b) cardiac chamber size i n t e r v e n t i o n s . and morphology; and (c) ventricular systolic and diastolic function, including left and right ventric- I V . P r o c e d u r e ular ejection fractions (LVEF and RVEF, respec- tively). An RVG may be acquired at rest, during A . Patient Preparation exercise, or after either pharmacologic or mechan- 1 . R e s t ical interventions. No special preparation is required for a rest- ing RVG. A fasting state is generally pre- ferred. It is not necessary to withhold any I I I . Common Indications medications. The electrodes used for cardiac A . Parameters obtained from RVG include the fol- gating must be placed securely on the skin to l o w i n g : ensure an optimal ECG signal. 1 . Global ventricular systolic function 2 . E x e r c i s e 2 . Regional wall motion The patient should be fasting for at least 3–4 3 . Ventricular volumes (qualitative or quanti- hours before the study and should be both t a t i v e ) hemodynamically and clinically stable. Ex- 4 . Responses of above parameters to exercise ercise stress, in the form of supine or upright or other interventions ergometry, is generally preferred. Patients 5 . Systolic and diastolic function indices who are unable to exercise for noncardiac 2 · RADIONUCLIDE VENTRICULOGRAPHY reasons may undergo pharmacologic stress preclude the performance of a study requiring with a positive inotropic agent. It is recom- physical exercise. A resting 12-lead ECG mended that medications that may alter the should be reviewed before an exercise study. heart rate response be withheld unless medi- C . P r e c a u t i o n s cally contraindicated or the efficacy of the 1 . It is mandatory that Occupational Safety medication is being tested by the exercise test. and Health Administration guidelines for Life support instrumentation and cardiac safe handling of human blood products be resuscitative drugs must be available in the followed at all times when techniques label- immediate vicinity of the stress laboratory. ing autologous RBCs are used. A physician or other personnel trained in 2 . When an in vitro method is used for radiola- advanced cardiac life support (ACLS) must beling autologous RBCs, a fail-safe policy be immediately available during the stress and procedure must be in place and imple- and recovery phases. Continuous, prefer- mented to assure that administration of la- ably 12-lead ECG monitoring must also be beled cells to the wrong patient is prevented. performed throughout all phases of the 3 . Patients with potentially unstable cardiac stress study. Intermittent blood pressure rhythms (e.g., paroxysmal supraventricular measurement and ECG tracings should be or ventricular tachycardia) or implanted de- performed before, during, and in the recov- vices (e.g., implantable defibrillators) may ery phases of the stress study. The patient require special precautions, because heart should be clinically observed during and rate response to exercise may be unpre- immediately after the stress test. Any abnor- d i c t a b l e . malities in symptomatology, hemodynam- D . R a d i o p h a r m a c e u t i c a l s ics, or the ECG should be monitored until re- For the adult, the usual administered activity is s o l v e d . 555–1110 MBq (15–30 mCi) autologous RBCs B . Information Pertinent to Performing the Proce- labeled with Tc-99m using the in vivo, modi- d u r e fied in vivo, or in vitro techniques. The usual An adequate history and cardiovascular exam- administered activity in children is 7–15 ination should be obtained before diagnostic MBq/kg (0.2–0.4 mCi/kg), with a minimum evaluation. Specific areas to be reviewed in- dose of 70–150 MBq (2–4 mCi). The largest ab- clude the indication(s) for testing, medications, sorbed radiation dose to an organ is that to the symptomatology, cardiac risk factors, and heart (about 0.02 mSv/MBq). Tc-99m–labeled prior cardiac procedures (diagnostic or thera- RBCs distribute within the blood-pool with an peutic). The patient’s cardiac rhythm should be estimated volume of distribution of approxi- noted, because marked heart rate variability mately 4%–7% of body weight. The estimated may limit the ability to both perform and inter- biological half-life is approximately 24–30 pret the RVG. Physical limitations may limit or hours. Approximately 25% of the administered Radiation Dosimetry for Adults Radiopharmaceutical Administered Organ Receiving the Effective activity largest radiation dose dose MBq mGy per MBq mSv per MBq (mCi) (rad per mCi) (rem per mCi) Tc-99m labeled 555 – 1110 i.v. 0.023 0.0085 red blood cells1 Heart (15 – 30) (0.085) (0.031) Tc-99m albumin2 370 – 740 i.v. 0.020 0.0079 Heart (10 – 20) (0.074) (0.029) 1ICRP 53, p. 210 2ICRP 53, p. 173 SOCIETY OF NUCLEAR MEDICINE PROCEDURE GUIDELINES MANUAL JUNE 2002 · 3 Radiation Dosimetry for Children (5 year old) Radiopharmaceutical Administered Organ receiving the Effective activity largest radiation dose dose MBq mGy per MBq mSv per MBq (mCi) (rad per mCi) (rem per mCi) Tc-99m labeled 7 – 15 i.v. 0.062 0.025 red blood cells1 Heart (0.2 – 0.4) (0.23) (0.093) Tc-99m albumin2 5 – 10 i.v. 0.054 0.023 Heart (0.1 – 0.3) (0.23) (0.085) 1ICRP 53, p. 210 2ICRP 53, p. 173 dose is excreted in the urine in the first 24 diac cycle from a heterogenous popula- hours. A stannous pyrophosphate preparation tion of beats and for retrograde gating for is typically used in most red cell labeling tech- diastolic parameters. niques. The dosage of this preparation may b . Acquisition parameters need to be increased in patients receiving “full- A minimum of 16 frames per R-R interval dose” heparin and in patients in renal failure. are required for an accurate assessment of Labeling is least consistent with the in vivo ventricular wall motion and assessment method, intermediate with the modified in of ejection fraction. A higher framing rate vivo method, and most consistent with the in (32–64 frames per R-R) is preferred for vitro method. Tc-99m–radiolabeled human detailed measurement of diastolic filling serum albumin (HSA) is an alternative to radi- parameters and is required for absolute olabeled RBCs. However, images are usually of volume measurements. Acceptable in- lower quality because of the escape of tracer dices of diastolic function are achievable from the intravascular space and breakdown of at 16 frames per cardiac cycle, if Fourier the albumin, resulting in decreased contrast. curve fitting is employed. E . Image Acquisition Images should be acquired so that the 1 . Rest study heart occupies ~50% of the usable field of a . I n s t r u m e n t a t i o n view. Typical acquisitions are for a total Acquisition is performed by a gamma of 3–7 million counts. Supine imaging is camera interfaced to a dedicated com- performed in a minimum of 3 views to vi- puter. Images may be acquired with ei- sualize all wall segments of the left ven- ther a low-energy all-purpose (LEAP) or tricle. The left anterior oblique (LAO) ac- high-resolution parallel-hole collimator.
Load more

Recommended publications
  • Nuclide Imaging: Planar Scintigraphy, SPECT, PET
    Nuclide Imaging: Planar Scintigraphy, SPECT, PET Yao Wang Polytechnic University, Brooklyn, NY 11201 Based on J. L. Prince and J. M. Links, Medical Imaging Signals and Systems, and lecture notes by Prince. Figures are from the textbook except otherwise noted. Lecture Outline • Nuclide Imaging Overview • Review of Radioactive Decay • Planar Scintigraphy – Scintillation camera – Imaging equation • Single Photon Emission Computed Tomography (SPECT) • Positron Emission Tomography (PET) • Image Quality consideration – Resolution, noise, SNR, blurring EL5823 Nuclear Imaging Yao Wang, Polytechnic U., Brooklyn 2 What is Nuclear Medicine • Also known as nuclide imaging • Introduce radioactive substance into body • Allow for distribution and uptake/metabolism of compound ⇒ Functional Imaging ! • Detect regional variations of radioactivity as indication of presence or absence of specific physiologic function • Detection by “gamma camera” or detector array • (Image reconstruction) From H. Graber, Lecture Note for BMI1, F05 EL5823 Nuclear Imaging Yao Wang, Polytechnic U., Brooklyn 3 Examples: PET vs. CT • X-ray projection and tomography: – X-ray transmitted through a body from a outside source to a detector (transmission imaging) – Measuring anatomic structure • Nuclear medicine: – Gamma rays emitted from within a body (emission imaging) From H. Graber, Lecture Note, F05 – Imaging of functional or metabolic contrasts (not anatomic) • Brain perfusion, function • Myocardial perfusion • Tumor detection (metastases) EL5823 Nuclear Imaging Yao Wang, Polytechnic
    [Show full text]
  • Description of Alternative Approaches to Measure and Place a Value on Hospital Products in Seven Oecd Countries
    OECD Health Working Papers No. 56 Description of Alternative Approaches to Measure Luca Lorenzoni, and Place a Value Mark Pearson on Hospital Products in Seven OECD Countries https://dx.doi.org/10.1787/5kgdt91bpq24-en Unclassified DELSA/HEA/WD/HWP(2011)2 Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 14-Apr-2011 ___________________________________________________________________________________________ _____________ English text only DIRECTORATE FOR EMPLOYMENT, LABOUR AND SOCIAL AFFAIRS HEALTH COMMITTEE Unclassified DELSA/HEA/WD/HWP(2011)2 Health Working Papers OECD HEALTH WORKING PAPERS NO. 56 DESCRIPTION OF ALTERNATIVE APPROACHES TO MEASURE AND PLACE A VALUE ON HOSPITAL PRODUCTS IN SEVEN OECD COUNTRIES Luca Lorenzoni and Mark Pearson JEL Classification: H51, I12, and I19 English text only JT03300281 Document complet disponible sur OLIS dans son format d'origine Complete document available on OLIS in its original format DELSA/HEA/WD/HWP(2011)2 DIRECTORATE FOR EMPLOYMENT, LABOUR AND SOCIAL AFFAIRS www.oecd.org/els OECD HEALTH WORKING PAPERS http://www.oecd.org/els/health/workingpapers This series is designed to make available to a wider readership health studies prepared for use within the OECD. Authorship is usually collective, but principal writers are named. The papers are generally available only in their original language – English or French – with a summary in the other. Comment on the series is welcome, and should be sent to the Directorate for Employment, Labour and Social Affairs, 2, rue André-Pascal, 75775 PARIS CEDEX 16, France. The opinions expressed and arguments employed here are the responsibility of the author(s) and do not necessarily reflect those of the OECD.
    [Show full text]
  • Myocardial Perfusion Imaging (Revised Edition)
    Publications · Brochures Myocardial Perfusion Imaging (Revised Edition) A Technologist’s Guide Produced with the kind Support of Editors Ryder, Helen (Dublin) Testanera, Giorgio (Rozzano, Milan) Veloso Jerónimo, Vanessa (Almada) Vidovič, Borut (Munich) Contributors Abreu, Carla (London) Koziorowski, Jacek (Linköping) Acampa, Wanda (Naples) Lezaic, Luka (Ljubljana) Assante, Roberta (Naples) Mann, April (South Hadley) Ballinger, James (London) Medolago, Giuseppe (Bergamo) Fragoso Costa, Pedro (Oldenburg) Pereira, Edgar (Almada) Figueredo, Sergio (Lisbon) Santos, Andrea (Alverca do Ribatejo) Geão, Ana (Lisbon) Vara, Anil (Brighton) Ghilardi, Adriana (Bergamo) Zampella, Emilia (Naples) Holbrook, Scott (Gray) Contents Foreword 4 Introduction 5 Borut Vidovič Chapter 1 State of the Art in Myocardial Imaging 6 Wanda Acampa, Emilia Zampella and Roberta Assante Chapter 2 Clinical Indications 16 Luka Lezaic Chapter 3 Patient Preparation and Stress Protocols 23 Giuseppe Medolago and Adriana Ghilardi EANM Chapter 4 Multidisciplinary Approach and Advanced Practice 35 Anil Vara Chapter 5 Advances in Radiopharmaceuticals for Myocardial Perfusion Imaging 42 James R. Ballinger and Jacek Koziorowski Chapter 6 SPECT and SPECT/CT Protocols and New Imaging Equipment 54 Andrea Santos and Edgar Lemos Pereira Chapter 7 PET/CT Protocols and Imaging Equipment (*) 62 April Mann and Scott Holbrook Chapter 8 Image Processing and Software 77 Sérgio Figueiredo and Pedro Fragoso Costa Chapter 9 Artefacts and Pitfalls in Myocardial Imaging (SPECT, SPECT/CT and PET/CT) 109 Ana Geão and Carla Abreu Imprint 126 n accordance with the Austrian Eco-Label for printed matters. Eco-Label with the Austrian for n accordance (*) Articles were written with the kind support Printed i Printed of and in cooperation with: 3 Foreword The EANM Technologist Committee was dural workflow and need to cooperate with created more than 20 years ago.
    [Show full text]
  • The Additive Value of Combined Assessment of Myocardial Perfusion and Ventricular Function Studies*
    The Additive Value of Combined Assessment of Myocardial Perfusion and Ventricular Function Studies* Trip J. Meine, MD1; Michael W. Hanson, MD1,2; and Salvador Borges-Neto, MD1,2 1Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina; and 2Division of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Durham, North Carolina This review focuses on the combined assessment of myo- In addition to providing quantitative ventricular function infor- cardial perfusion imaging and left ventricular function. Two mation, gated SPECT and radionuclide angiocardiographic clear roles for nuclear imaging in clinical practice include studies can evaluate regional wall motion and ventricular vol- the diagnosis of coronary artery disease (CAD) and assess- umes. This review focuses on the combined assessment of ment of prognosis in patients with known CAD. Combined myocardial perfusion and left ventricular function. Two clear roles for nuclear imaging in clinical practice include the diagno- nuclear imaging can play a role in both these areas, and in sis of coronary artery disease and assessment of prognosis in fact, the addition of left ventricular function data to myo- patients with known coronary artery disease. Ventricular func- cardial perfusion imaging can enhance the clinician’s ability tion information can help differentiate an attenuation artifact to both diagnose CAD and assess prognosis. from an infarct and is helpful in diagnosing 3-vessel coronary disease. Additionally, several studies have highlighted the prog- nostic benefit to combined assessment of myocardial perfusion DIAGNOSIS and ventricular function. Several new modalities have recently Assessment of ventricular function has long been recog- been reported that promise to continue to solidify the place of nuclear imaging in the diagnosis and prognosis of coronary nized as a sensitive means by which to diagnose the pres- artery disease.
    [Show full text]
  • Equilibrium Radionuclide Angiography/ Multigated Acquisition
    EQUILIBRIUM RADIONUCLIDE ANGIOGRAPHY/ MULTIGATED ACQUISITION Equilibrium Radionuclide Angiography/ Multigated Acquisition S van Eeckhoudt, Bravis ziekenhuis, Roosendaal VJR Schelfhout, Rijnstate, Arnhem 1. Introduction Equilibrium radionuclide angiography (ERNA), also known as radionuclide ventriculography (ERNV), gated synchronized angiography (GSA), blood pool scintigraphy or multi gated acquisition (MUGA), is a well-validated technique to accurately determine cardiac function. In oncology its high reproducibility and low inter observer variability allow for surveillance of cardiac function in patients receiving potentially cardiotoxic anti-cancer treatment. In cardiology it is mostly used for diagnosis and prognosis of patients with heart failure and other heart diseases. 2. Methodology This guideline is based on available scientifi c literature on the subject, the previous guideline (Aanbevelingen Nucleaire Geneeskunde 2007), international guidelines from EANM and/or SNMMI if available and applicable to the Dutch situation. 3. Indications Several Class I (conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective) indications exist: • Evaluation of left ventricular function in cardiac disease: - Coronary artery disease - Valvular heart disease - Congenital heart disease - Congestive heart failure • Evaluation of left ventricular function in non-cardiac disease: - Monitoring potential cardiotoxic side effects of (chemo)therapy - Pre-operative risk stratifi cation in high risk surgery • Evaluation of right ventricular function: - Congenital heart disease - Mitral valve insuffi ciency - Heart-lung transplantation 4. Contraindications None 5. Medical information necessary for planning • Clear description of the indication (left and/or right ventricle) • Previous history of cardiac disease • Previous or current use of cardiotoxic medication PART I - 211 Deel I_C.indd 211 27-12-16 14:15 EQUILIBRIUM RADIONUCLIDE ANGIOGRAPHY/ MULTIGATED ACQUISITION 6.
    [Show full text]
  • Planar Imaging Versus Gated Blood-Pool SPECT for the Assessment of Ventricular Performance: a Multicenter Study
    Planar Imaging Versus Gated Blood-Pool SPECT for the Assessment of Ventricular Performance: A Multicenter Study Mark W. Groch, E. Gordon DePuey, Allan C. Belzberg, William D. Erwin, Mohammad Kamran, Charles A. Barnett, Robert C. Hendel, Stewart M. Spies, Amjad Ali, and Robert C. Marshall Northwestern University Medical School, Chicago; Rush-Presbyterian-St. Luke’s Medical Center, Chicago; Rush University, Chicago, Illinois; St. Luke’s-Roosevelt Hospital, New York; Columbia University, New York, New York; St. Paul’s Hospital, Vancouver, British Columbia; University of British Columbia, Vancouver, British Columbia, Canada; VA Medical Center, Martinez; University of California-Davis, Davis; and Lawrence Berkeley National Laboratory, Berkeley, California Gated blood-pool SPECT (GBPS), inherently 3-dimensional (3D), Planar equilibrium radionuclide angiography (ERNA) is has the potential to replace planar equilibrium radionuclide angiog- well established and provides a relatively simple and non- raphy (ERNA) for computation of left ventricular ejection fraction invasive method to assess ventricular function and, in par- (LVEF), analysis of regional wall motion (RWM), and analysis of right heart function. The purpose of this study was to compare ticular, left ventricular ejection fraction (LVEF) (1,2). In GBPS and ERNA for the assessment of ventricular function in a any planar projection imaging study, anatomic structures large, multicenter cohort of patients. Methods: One hundred sev- overlap. In planar equilibrium blood-pool imaging, the in- enty-eight patients referred in the usual manner for nuclear medi- ferior wall of the left ventricle is obscured by the right cine studies underwent ERNA followed by GBPS. Each clinical site ventricle in anterior and right anterior oblique (RAO) pro- followed a GBPS acquisition protocol that included 180° rotation, jections, and the left atrium may partially overlap, posteri- a 64 by 64 matrix, and 64 or 32 views using single- or double-head cameras.
    [Show full text]
  • Pdf 296.03 K
    Original Article Evaluation of myocardial perfusion and function after kidney transplantation by Gated SPECT myocardial perfusion scintigraphy Armaghan Fard-Esfahani1, Babak Fallahi1, Sahar Mirpour 1, Ali Gholamrezanezhad1, Ezatollah Abdi2, Mohammad Karimi1, Davood Beiki1, Alireza Emami-Ardekani1, Fariba Akhzari3, Mojtaba Ansari4, Mohammad Eftekhari1 1 Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran 2 Hasheminejad Kidney Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 3 Nuclear Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran 4 Nuclear Medicine Department, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran (Received 12 September 2012, Revised 14 October 2012, Accepted 20 October 2012) ABSTRACT Introduction: The aim of this study was to evaluate the effect of successful kidney transplantation (KT) on myocardial perfusion and left ventricular function by both qualitative (visual) interpretation and semiquantitative parameters, using myocardial perfusion scintigraphy with gated-single photon emission computed tomography (gated-SPECT) in patients suffering from end-stage renal disease. Methods: From a total of 38 patients who were candidates of KT, twenty-six patients (16 female, 10 male, mean age: 47.5 yr, range: 24-64 yr) who had successful KT were included. Myocardial perfusion scintigraphy was performed by Gated Single Photon Emission Computed Tomography (Gated-SPECT) method, before and after surgery (mean: 24 months). Perfusion and function status was evaluated by qualitative and semiquantitative parameters. Results: Our data showed qualitative evidence of perfusion and functional abnormality in pre-transplant scans as follows: Abnormal perfusion in left anterior descending (LAD), left circumflex (LCX) and right coronary artery (RCA) territories in 42.5%, 53.8% and 65.4% of cases, respectively; dilation in 57.7% and inhomogenity of uptake in 53.8% of cases.
    [Show full text]
  • A Common Occurrence After Coronary Bypass Surgery
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector lACC Vol. 15, No.6 1261 May 1990:1261-9 Acute Myocardial Dysfunction and Recovery: A Common Occurrence After Coronary Bypass Surgery WARREN M. BREISBLATT, MD, FACC, KEITH L. STEIN, MD, CYNTHIA J. WOLFE, RN, WILLIAM P. FOLLANSBEE, MD, FACC, JOHN CAPOZZI, CNMT, JOHN M. ARMITAGE, MD, ROBERT L. HARDESTY, MD, FACC Pittsburgh, Pennsylvania To evaluate whether acute myocardial dysfunction was min after coronary bypass and showed complete recovery common in the early postoperative period, serial hemody• within 48 h. Left ventricular end-systolic and end-diastolic namic measurements and radionuclide evaluation of ven• volume index increased significantly postoperatively, but tricular function were performed before and after opera• recovery in left ventricular ejection fraction was mostly due tion in 24 patients undergoing elective coronary bypass to decreases in end-systolic volume index (50 ± 22 ml at surgery. All patients had uncomplicated surgery, and no trough and 32 ± 16 ml at recovery). Depressed myocardial patient sustained an intraoperative infarction. In 96% of function was independent of bypass time, number of grafts patients, significant depression in right and left ventricular placed, preoperative medications or core temperatures ejection fraction was seen postoperatively, reaching a nadir postoperatively. Postoperative therapy with pressors or at 262 ± 116 min after coronary bypass. Left ventricular inotropic agents delayed but did
    [Show full text]
  • Presentation and Evaluation of Gated-SPECT Myocardial Perfusion Images
    Presentation and evaluation of gated-SPECT myocardial perfusion images Niloufar Darvish F.Nadideh Öçba Master of Science Thesis in Medical Imaging Stockholm 2013 i This master thesis project was performed in collaboration with [Karolinska university hospital-Thorax] Supervisor at [Karolinska hospital]: Dianna Bone Presentation and evaluation of gated-SPECT myocardial perfusion images Niloufar Darvish F.Nadideh Öçba Master of Science Thesis in Medical Imaging 30credits Supervisor at KTH: Hamed Hamid Muhammad Examinator: Fredrik Bergholm School of Technology and Health TRITA-STH. EX 2011:51 Royal Institute of Technology KTH STH SE-141 86 Flemingsberg, Sweden http://www.kth.se/sth ii Abstract Single photon emission tomography (SPECT) data from myocardial perfusion imaging (MPI) are normally displayed as a set of three slices orthogonal to the left ventricular (LV) long axis for both ECG-gated (GSPECT) and non-gated SPECT studies. The total number of slices presented for assessment depends on the size of the heart, but is typically in excess of 30. A requirement for data presentation is that images should be orientated about the LV axis; therefore, a set of radial slice would fulfill this need. Radial slices are parallel to the LV long axis and arranged diametrically. They could provide a suitable alternative to standard orthogonal slices, with the advantage of requiring far fewer slices to adequately represent the data. In this study a semi-automatic method was developed for displaying MPI SPECT data as a set of radial slices orientated about the LV axis, with the aim of reducing the number of slices viewed, without loss of information and independent on the size of the heart.
    [Show full text]
  • Gated SPECT Myocardial Perfusion Imaging with Cadmium-Zinc-Telluride Detectors Allows Real-Time Assessment of Dobutamine-Stress
    ORIGINAL ARTICLE Gated SPECT myocardial perfusion imaging with cadmium-zinc-telluride detectors allows real- time assessment of dobutamine-stress-induced wall motion abnormalities Rene Nkoulou, MD,a,b Mathias Wolfrum, MD,a Aju P. Pazhenkottil, MD,a Michael Fiechter, MD,a Ronny R. Buechel, MD,a Oliver Gaemperli, MD,a and Philipp A. Kaufmann, MDa a Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland b Department of Cardiology, University Hospital Geneva, Geneva, Switzerland Received Mar 25, 2017; accepted Dec 18, 2017 doi:10.1007/s12350-018-1187-x Background. Left ventricular (LV) ejection fraction (EF) during high dobutamine stress (HD) by real-time gated-SPECT myocardial perfusion imaging (MPI) on a cadmium-zinc- telluride (CZT) gamma camera was validated versus cardiac magnetic resonance imaging (CMR). Methods and results. After injecting 99mTc-tetrofosmin (320 MBq) in 50 patients (mean age 64 1/2 11 years), EF at rest and post-stress as well as relevant changes in EF at HD (DEF ‡ 5%) were assessed. CZT and CMR rest EF values yielded an excellent correlation and agreement (r = 0.96; P < 0.001; Bland–Altman limits of agreement (BA): 1 0 to 14.8%). HD EF acquisition was feasible using CZT and correlated better to HD CMR EF than did post-stress CZT EF (r = 0.85 vs 0.76, respectively, all P < 0.001). Agreement in DEF detection between HD CMR and immediate post-stress CZT (reflecting standard acquisition using conventional SPECT camera unable to scan during stress) was 45%, while this increased to 85% with real- time HD CZT scan.
    [Show full text]
  • Procedure Guideline for Planar Radionuclide Cardiac
    Procedure Guideline for Planar Radionuclide Cardiac Ventriculogram for the Assessment of Left Ventricular Systolic Function Version 2 2016 Review date 2021 a b c d e e Alice Nicol , Mike Avison , Mark Harbinson , Steve Jeans , Wendy Waddington , Simon Woldman (on behalf of BNCS, BNMS, IPEM). a b Southern General Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK Bradford Royal Infirmary, c d e Bradford, UK Queens University, Belfast, UK Christie Hospital NHS Foundation Trust, Manchester, UK University College London Hospitals NHS Foundation Trust, London, UK 1 1. Introduction The purpose of this guideline is to assist specialists in nuclear medicine in recommending, performing, interpreting and reporting radionuclide cardiac ventriculograms (RNVG), also commonly known as multiple gated acquisition (MUGA) scans. It will assist individual departments in the development and formulation of their own local protocols. RNVG is a reliable and robust method of assessing cardiac function [1-5]. The basis of the study is the acquisition of a nuclear medicine procedure with multiple frames, gated by the R wave of the electrocardiogram (ECG) signal. The tracer is a blood pool agent, usually red blood cells labelled with technetium-99m (99mTc). One aim of this guideline is to foster a more uniform method of performing RNVG scans throughout the United Kingdom. This is particularly desirable since the National Institute for Health and Clinical Excellence (NICE) has mandated national protocols for the pre-assessment and monitoring of patients undergoing certain chemotherapy regimes [6, 7], based on specific left ventricular ejection fraction (LVEF) criteria. This guideline will focus on planar equilibrium RNVG scans performed for the assessment of left ventricular systolic function at rest, using data acquired in the left anterior oblique (LAO) projection by means of a frame mode, ECG-gated acquisition method.
    [Show full text]
  • Variability in Ejection Fraction Measured by Echocardiography
    Touro Scholar NYMC Faculty Publications Faculty 8-1-2018 Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction P. A. Pellikka Lilin She T. A. Holly G. Lin P. Varadarajan See next page for additional authors Follow this and additional works at: https://touroscholar.touro.edu/nymc_fac_pubs Part of the Medicine and Health Sciences Commons Recommended Citation Pellikka, P., She, L., Holly, T., Lin, G., Varadarajan, P., Panza, J., & Oh, J. (2018). Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction. JAMA Network Open, 1 (4), e181456. https://doi.org/10.1001/jamanetworkopen.2018.1456 This Article is brought to you for free and open access by the Faculty at Touro Scholar. It has been accepted for inclusion in NYMC Faculty Publications by an authorized administrator of Touro Scholar. For more information, please contact [email protected]. Authors P. A. Pellikka, Lilin She, T. A. Holly, G. Lin, P. Varadarajan, Julio Panza, and J. K. Oh This article is available at Touro Scholar: https://touroscholar.touro.edu/nymc_fac_pubs/1547 Original Investigation | Cardiology Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction Patricia A. Pellikka, MD; Lilin She, PhD; Thomas A. Holly, MD; Grace Lin, MD; Padmini Varadarajan, MD; Ramdas G. Pai, MD; Robert O. Bonow, MD, MS; Gerald M.
    [Show full text]